narvo vexar
Dassault Systèmes (DASTY) is in discussions to acquire drug trial software maker ArisGlobal from Nordic Capital for about $2 billion.
Talks between the parties are ongoing, according to a Financial Times report on Thursday, which cited people familiar with the matter. A deal